2016 Hematological Malignancies

HD12 patients with bulk only (PFS; n=402)

PFS from RE2 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0

Bulk only (n= 402) Overall 5 yr. PFS

92.5%

Arm difference (5 yrs.)

-1.4%[-6.8%, 4.0%]

Log-Rank test

p=0.381

RT given: RT vs. No RT

86.7% vs 2.3%

p = 0.381

Radiotherapy Arm

30 Gy RT

no RT

0

12

24

36

48

60

72

84

Time [months]

30 Gy RT no RT Pts. at Risk

181 221

169 205

165 196

157 187

142 172

101 131

66 75

33 32